Cancer Cell–Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma

The prognosis for pancreatic ductal adenocarcinoma (PDAC) remains poor despite decades of effort. The abundant extracellular matrix (ECM) in PDAC comprises a major fraction of the tumor mass and plays various roles in promoting resistance to therapies. However, nonselective depletion of ECM has led...

Full description

Bibliographic Details
Main Authors: Tian, Chenxi, Öhlund, Daniel, Rickelt, Steffen, Lidström, Tommy, Huang, Ying, Hao, Liangliang, Zhao, Renee T, Franklin, Oskar, Bhatia, Sangeeta N, Tuveson, David A., Hynes, Richard O
Other Authors: Harvard University--MIT Division of Health Sciences and Technology
Format: Article
Language:English
Published: American Association for Cancer Research (AACR) 2020
Online Access:https://hdl.handle.net/1721.1/128828
_version_ 1826191149491027968
author Tian, Chenxi
Öhlund, Daniel
Rickelt, Steffen
Lidström, Tommy
Huang, Ying
Hao, Liangliang
Zhao, Renee T
Franklin, Oskar
Bhatia, Sangeeta N
Tuveson, David A.
Hynes, Richard O
author2 Harvard University--MIT Division of Health Sciences and Technology
author_facet Harvard University--MIT Division of Health Sciences and Technology
Tian, Chenxi
Öhlund, Daniel
Rickelt, Steffen
Lidström, Tommy
Huang, Ying
Hao, Liangliang
Zhao, Renee T
Franklin, Oskar
Bhatia, Sangeeta N
Tuveson, David A.
Hynes, Richard O
author_sort Tian, Chenxi
collection MIT
description The prognosis for pancreatic ductal adenocarcinoma (PDAC) remains poor despite decades of effort. The abundant extracellular matrix (ECM) in PDAC comprises a major fraction of the tumor mass and plays various roles in promoting resistance to therapies. However, nonselective depletion of ECM has led to poor patient outcomes. Consistent with that observation, we previously showed that individual matrisome proteins derived from stromal cells correlate with either long or short patient survival. In marked contrast, those derived from cancer cells correlate strongly with poor survival. Here, we studied three cancer cell–derived matrisome proteins that are significantly overrepresented during PDAC progression, AGRN (agrin), SERPINB5 (serine protease inhibitor B5), and CSTB (cystatin B). Using both overexpression and knockdown experiments, we demonstrate that all three are promoters of PDAC metastasis. Furthermore, these proteins operate at different metastatic steps. AGRN promoted epithelial-to-mesenchymal transition in primary tumors, whereas SERPINB5 and CSTB enhanced late steps in the metastatic cascade by elevating invadopodia formation and in vivo extravasation. All three genes were associated with a poor prognosis in human patients and high levels of SERPINB5, secreted by cancer cells and deposited in the ECM, correlated with poor patient prognosis. This study provides strong evidence that cancer cell–derived matrisome proteins can be causal in promoting tumorigenesis and metastasis and lead to poor patient survival. Therefore, compared with the bulk matrix, mostly made by stromal cells, precise interventions targeting cancer cell–derived matrisome proteins, such as AGRN, SERPINB5, and CSTB, may represent preferred potential therapeutic targets.
first_indexed 2024-09-23T08:51:00Z
format Article
id mit-1721.1/128828
institution Massachusetts Institute of Technology
language English
last_indexed 2024-09-23T08:51:00Z
publishDate 2020
publisher American Association for Cancer Research (AACR)
record_format dspace
spelling mit-1721.1/1288282022-09-26T08:46:35Z Cancer Cell–Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma Tian, Chenxi Öhlund, Daniel Rickelt, Steffen Lidström, Tommy Huang, Ying Hao, Liangliang Zhao, Renee T Franklin, Oskar Bhatia, Sangeeta N Tuveson, David A. Hynes, Richard O Harvard University--MIT Division of Health Sciences and Technology Massachusetts Institute of Technology. Department of Biology Koch Institute for Integrative Cancer Research at MIT The prognosis for pancreatic ductal adenocarcinoma (PDAC) remains poor despite decades of effort. The abundant extracellular matrix (ECM) in PDAC comprises a major fraction of the tumor mass and plays various roles in promoting resistance to therapies. However, nonselective depletion of ECM has led to poor patient outcomes. Consistent with that observation, we previously showed that individual matrisome proteins derived from stromal cells correlate with either long or short patient survival. In marked contrast, those derived from cancer cells correlate strongly with poor survival. Here, we studied three cancer cell–derived matrisome proteins that are significantly overrepresented during PDAC progression, AGRN (agrin), SERPINB5 (serine protease inhibitor B5), and CSTB (cystatin B). Using both overexpression and knockdown experiments, we demonstrate that all three are promoters of PDAC metastasis. Furthermore, these proteins operate at different metastatic steps. AGRN promoted epithelial-to-mesenchymal transition in primary tumors, whereas SERPINB5 and CSTB enhanced late steps in the metastatic cascade by elevating invadopodia formation and in vivo extravasation. All three genes were associated with a poor prognosis in human patients and high levels of SERPINB5, secreted by cancer cells and deposited in the ECM, correlated with poor patient prognosis. This study provides strong evidence that cancer cell–derived matrisome proteins can be causal in promoting tumorigenesis and metastasis and lead to poor patient survival. Therefore, compared with the bulk matrix, mostly made by stromal cells, precise interventions targeting cancer cell–derived matrisome proteins, such as AGRN, SERPINB5, and CSTB, may represent preferred potential therapeutic targets. 2020-12-14T23:19:31Z 2020-12-14T23:19:31Z 2020-02 2019-12 2020-12-02T18:16:09Z Article http://purl.org/eprint/type/JournalArticle 0008-5472 1538-7445 https://hdl.handle.net/1721.1/128828 Tian, Chenxi et al. "Cancer Cell–Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma." Cancer Research 80, 7 (February 2020): dx.doi.org/10.1158/0008-5472.can-19-2578 © 2020 American Association for Cancer Research en http://dx.doi.org/10.1158/0008-5472.can-19-2578 Cancer Research Creative Commons Attribution-Noncommercial-Share Alike http://creativecommons.org/licenses/by-nc-sa/4.0/ application/pdf American Association for Cancer Research (AACR) PMC
spellingShingle Tian, Chenxi
Öhlund, Daniel
Rickelt, Steffen
Lidström, Tommy
Huang, Ying
Hao, Liangliang
Zhao, Renee T
Franklin, Oskar
Bhatia, Sangeeta N
Tuveson, David A.
Hynes, Richard O
Cancer Cell–Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma
title Cancer Cell–Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma
title_full Cancer Cell–Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma
title_fullStr Cancer Cell–Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma
title_full_unstemmed Cancer Cell–Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma
title_short Cancer Cell–Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma
title_sort cancer cell derived matrisome proteins promote metastasis in pancreatic ductal adenocarcinoma
url https://hdl.handle.net/1721.1/128828
work_keys_str_mv AT tianchenxi cancercellderivedmatrisomeproteinspromotemetastasisinpancreaticductaladenocarcinoma
AT ohlunddaniel cancercellderivedmatrisomeproteinspromotemetastasisinpancreaticductaladenocarcinoma
AT rickeltsteffen cancercellderivedmatrisomeproteinspromotemetastasisinpancreaticductaladenocarcinoma
AT lidstromtommy cancercellderivedmatrisomeproteinspromotemetastasisinpancreaticductaladenocarcinoma
AT huangying cancercellderivedmatrisomeproteinspromotemetastasisinpancreaticductaladenocarcinoma
AT haoliangliang cancercellderivedmatrisomeproteinspromotemetastasisinpancreaticductaladenocarcinoma
AT zhaoreneet cancercellderivedmatrisomeproteinspromotemetastasisinpancreaticductaladenocarcinoma
AT franklinoskar cancercellderivedmatrisomeproteinspromotemetastasisinpancreaticductaladenocarcinoma
AT bhatiasangeetan cancercellderivedmatrisomeproteinspromotemetastasisinpancreaticductaladenocarcinoma
AT tuvesondavida cancercellderivedmatrisomeproteinspromotemetastasisinpancreaticductaladenocarcinoma
AT hynesrichardo cancercellderivedmatrisomeproteinspromotemetastasisinpancreaticductaladenocarcinoma